Tag: Predilife
Colas: something new with PREDILIFE
HC Published on 04/11/2023 at 9:51 p.m. Photo credit © Colas (Boursier.com) — Colas Rail, the…
Predilife: contract with Colas for a predictive assessment
(CercleFinance.com) – Predilife announces a contract with Colas Rail, under which this railway infrastructure builder and subsidiary of the Bouygues conglomerate, now offers Predilife’s predictive breast cancer assessment to its…
PREDILIFE: PREDILIFE SUPPORTS COLAS RAIL TO TAKE CARE OF ITS EMPLOYEES WITH THE PREDICTIVE ASSESSMENT OF BREAST CANCER – 04/11/2023 at 18:40
Villejuif, France, April 11, 2023 at 6:30 p.m. CET – Colas Rail, the international leader in rail infrastructure, now offers the predictive breast cancer assessment from PREDILIFE (Euronext Growth: ALPRE…
Predilife joins Impulse Partners’ Construction Health and Prevention platform – 2023-02-28 at 18:18
(AOF) – The Predilife health offer has been selected to integrate Impulse Partners’ Health and Construction Prevention platform. This platform aims to highlight innovative health, safety and risk prevention solutions…
Predilife integrates the Health and Prevention platform of the construction industry
By Alexandra Saintpierre Published on 02/28/2023 at 8:16 p.m. Photo credit © Predilife (Boursier.com) — Predilife a…
PREDILIFE: AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT – 2023/02/17 at 6:30 pm
Villejuif, France, February 17, 2023 at 6:30 p.m. CET – PREDILIFE (Euronext Growth: ALPRE FR0010169920), a specialist in artificial intelligence methods for predicting the risks of pathologies for personalized medicine,…
Predilife: details on turnover
Through Alexandra Saintpierre Published on 01/31/2023 at 6:18 p.m. Photo credit © Predilife (Boursier.com) — Predilife a…
PREDILIFE : PREDILIFE: INITIATION OF COVERAGE BY IN EXTENSO/ PRICE OBJECTIVE AT 9.76 EUROS – 01/11/2023 at 6:00 p.m.
INITIATION OF COVERAGE BY IN EXTENSO PRICE TARGET AT 9.76 EUROS Villejuif, France, January 11, 2023 at 6:00 p.m. CET – PREDILIFE (Euronext Growth: ALPRE FR0010169920), specialist in innovative pathology…
Personalized medicine: Predilife multiplied its sales by 2.6 in 2022 – 01/04/2023 at 18:19
(AOF) – Predilife, a specialist in innovative pathology risk prediction solutions for personalized medicine, achieved a sales volume of 370,000 euros in 2022, i.e. a multiplication by 2.6 compared to…
PREDILIFE: LACTALIS FRANCE OFFERS A SCREENING CAMPAIGN WITH THE PREDILIFE BREAST CANCER PREDICTIVE ASSESSMENT – 08/12/2022 at 18:30
Villejuif, December 8, 2022, 6:30 p.m. – Lactalis France is launching a screening campaign for all of its employees from the age of 40 with the predictive assessment of breast…
Predilife launches Mammorisk tests at the Veneto Oncology Institute – 23/11/2022 at 18:19
(AOF) – Predilife (specialist in innovative pathology risk prediction solutions for personalized medicine) announces the launch of Mammorisk tests at the Veneto Institute of Oncology. Located in Padua, this institute…
PREDILIFE: Predilife extends its network of partner insurance brokers: Roederer integrates Multi-pathology Prevention Reports into its health offer – 2022-11-16 at 18:00
Villejuif, France, November 16, 2022, 6 p.m. – PREDILIFE (Euronext Growth: ALPRE FR0010169920), a specialist in innovative pathology risk prediction solutions for personalized medicine, is pleased to announce a partnership…